NEW YORK–(BUSINESS WIRE)–Avoro Ventures, a global venture capital firm investing in life sciences, announced today that Mark Chin has joined the firm as a Partner, focused on its venture capital investment efforts. Mark has 15 years of healthcare experience across venture capital, strategy consulting, business and corporate development. Prior to joining Avoro Ventures, Mark was …
Year: 2023
Hemab Therapeutics Announces $135M Series B Financing to Advance First Prophylactic Treatments for Underserved Bleeding and Thrombotic Disorders
Funding enables completion of ongoing Phase 1/2 study of bispecific antibody HMB-001 in Glanzmann Thrombasthenia, initiation of pivotal studies, start and conclusion of Phase 1/2 study of HMB-VWF in von Willebrand Disease, as well as future pipeline evolution. COPENHAGEN, DENMARK and BOSTON, MASS., US – February 21, 2023 Hemab Therapeutics, a clinical-stage biotechnology company developing …
+1 212.937.4970
info@avorocapital.com